Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition-Reference-Cited by-同舟云学术

Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition

Published:2021-10-21 Issue:7-8 Volume:66 Page:90-98
ISSN:0235-2990
Container-title:Antibiotics and Chemotherapy
language:
Short-container-title:A&Ch

Author:

Kocherovets V. I.¹,Mardanly S. G.¹

Affiliation:

1. I. M. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

One of the most used antimicrobial nitrofurans in Russian medical practice is nifuroxazide, which is distinguished by high therapeutic eﬃcacy, drug safety, as well as economic availability in the treatment of acute bacterial diarrhea without deterioration of the general condition, fever, and intoxication. In the Russian Federation (RF), nifuroxazide preparations in general circulation are supplied by 19 domestic and foreign pharmaceutical organizations. The aim of this study was to analyze the nomenclature, as well as chemical and pharmaceutical characteristics of excipients (EXs) in the composition of nifuroxazide preparations, which received state registration in the RF. A comparative study of the chemical and pharmaceutical characteristics of EXs of 42 nifuroxazide preparations in the form of capsules, tablets, and suspension for oral administration was carried out. The pharmaco-economic status is noted and the demand prospects for all forms of nifuroxazide preparations in the RF are outlined. Quantitative and qualitative diﬀerences in the composition of the EXs of a number of nifuroxazide preparations in the form of capsules and suspensions has been shown.

Publisher

Publishing House OKI

Subject

Infectious Diseases,Microbiology (medical),General Medicine,Microbiology

Reference36 articles.

1. Gosudarstvennyj Reestr lekarstvennykh sredstv i izdelij meditsinskogo naznacheniya. Oﬁtsial'noe izdanie na 1 ijyulya 1994 g. Moscow: 1994; 512. (in Russian)

2. Gosudarstvennyj Reestr lekarstvennykh sredstv i izdelij meditsinskogo naznacheniya. Oﬁtsial'noe izdanie na 1 avgusta 1996 g. Moscow: 1996; 608. (in Russian)

3. Gosudarstvennyj Reestr lekarstvennykh sredstv i izdelij meditsinskogo naznacheniya. Oﬁtsial'noe izdanie na 1 yanvarya 2000 g. Moscow: 2000; 1202. (in Russian)

4. Bredoux P. Le traitement des diarrheas du nourrisson et de L’enfant de Nifuroxazide. L'Hospital. Information Therapeutics. 1970; 1: 1.

5. Santiago T., Ranoa C. P., Chan E. G.,Tejada E. Lourdes nifuroxazide (Ercefuryl) plus oral rehydration solution versus oral rehydration alone in hospitalized pediatric gastroenteritis. Phil J Microbiol Infect Dis. 1985; 14 (2): 76–79.